Glenn Van Aller - Concepedia

Author

Glenn Van Aller

Also Known As

G Van Aller, G van Aller, G. Van Aller, G. van Aller, GLENN VAN ALLER, Glenn Van Aller, Glenn Van Aller, Glenn van Aller

Publications

266

Citations

H-Index

Concepts

All Affiliations

Glenn Van Aller is an author at Sterling Research Group (United States) specializing in medicine, drug discovery, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	147
2	Natural Sciences	1	1	118
3	Biochemistry	1	1	118
4	Cell Biology	1	1	118
5	Pharmacology	1	1	29

Glenn Van Aller

Publications

243

Citations

H-Index

Page 1

	Year	Citations
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase Jeffrey D. Carson, Glenn Van Aller, Ruth Lehr, Biochemical Journal Signal TransductionSignaling PathwayBiochemistryClass Ia Pi3ksNatural Sciences	2007	118
Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid Leukemia Ryan G. Kruger, Helai P. Mohammad, Kimberly N. Smitheman, Blood	2013	30
212 Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552 H. Mohammad, Kimberly N. Smitheman, Glenn Van Aller, European Journal of Cancer Molecular PharmacologyLsd1 InhibitionDrug TargetDrug TargetingMedicine	2014	29
Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor. Paul J. Silver, Ronald L. Dundore, D C Bode, Journal of Pharmacology and Experimental Therapeutics	1994	25
Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine. Paul J. Silver, Brendan O’Connor, Wayne R. Cumiskey, Journal of Pharmacology and Experimental Therapeutics	1991	24
The Effects of Iodixanol and Iopamidol on Hemodynamic and Cardiac Electrophysiologic Parameters In Vitro and In Vivo Ronald L. Dundore, Paul J. Silver, Alan M. Ezrin, Investigative Radiology	1991	17

Page 1